Nail Psoriasis.
Canal-García E, Bosch-Amate X, Belinchón I, Puig L.
Actas Dermosifiliogr. 2022 May;113(5):481-490. doi: 10.1016/j.ad.2022.01.006. Epub 2022 Feb 2.
Nail psoriasis and nail lichen planus: Updates on diagnosis and management.
Hwang JK, Grover C, Iorizzo M, Lebwohl MG, Piraccini BM, Rigopoulos DG, Lipner SR.
J Am Acad Dermatol. 2024 Mar;90(3):585-596. doi: 10.1016/j.jaad.2023.11.024. Epub 2023 Nov 24.
Challenge of Nail Psoriasis: An Update Review.
Ji C, Wang H, Bao C, Zhang L, Ruan S, Zhang J, Gong T, Cheng B.
Clin Rev Allergy Immunol. 2021 Dec;61(3):377-402. doi: 10.1007/s12016-021-08896-9. Epub 2021 Sep 3.
Management of Nail Psoriasis.
Rigopoulos D, Rompoti N, Gregoriou S.
Dermatol Clin. 2021 Apr;39(2):211-220. doi: 10.1016/j.det.2020.12.014. Epub 2021 Feb 11.
Management of nail psoriasis.
Thomas L, Azad J, Takwale A.
Clin Exp Dermatol. 2021 Jan;46(1):3-8. doi: 10.1111/ced.14314. Epub 2020 Aug 2.
Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis.
Rich P, Scher RK.
J Am Acad Dermatol. 2003 Aug;49(2):206-12. doi: 10.1067/s0190-9622(03)00910-1.
Nail Psoriasis in Older Adults: Epidemiology, Diagnosis, and Topical Therapy.
Ricardo JW, Lipner SR.
Dermatol Clin. 2021 Apr;39(2):183-193. doi: 10.1016/j.det.2020.12.011. Epub 2021 Feb 11.
Nail Psoriasis Treatment: Insights into Current Progress and Future Trends.
Nirbhavane P, Sharma G, Verma S, Jadon RS, Singh B, Katare OP.
Crit Rev Ther Drug Carrier Syst. 2020;37(2):135-159. doi: 10.1615/CritRevTherDrugCarrierSyst.2020029259.
Nail Psoriasis in Older Adults: Intralesional, Systemic, and Biological Therapy.
Ricardo JW, Lipner SR.
Dermatol Clin. 2021 Apr;39(2):195-210. doi: 10.1016/j.det.2020.12.012. Epub 2021 Feb 10.
Optimal diagnosis and management of common nail disorders.
Lee DK, Lipner SR.
Ann Med. 2022 Dec;54(1):694-712. doi: 10.1080/07853890.2022.2044511.
